The goings - on with Admedus reminds me of the trials and tribulations Avita (AVH) went through over almost two decades before finally receiving FDA approval for its Recell. Although it had potentially a world class burns treatment, its progress was held up over the journey by questionable management, a revolving door of management personnel, shortage of money, recapitalisations and time consuming research and development requirements.
Despite all the headwinds AVH finally achieved its first goal of FDA approval recently.
Admedus is following a similar path with potentially a world class product, but needs people who know what they are doing and how to capitalise on what has been achieved so far.
Hopefully the new Board members and ownership will steer Admedus in the right direction.
The goings - on with Admedus reminds me of the trials and...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $294.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |